{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:30:19Z","timestamp":1794000619154,"version":"4.8.0"},"reference-count":202,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["Basal funding for Scientific"],"award-info":[{"award-number":["Basal funding for Scientific"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["Technological Center of Excellence"],"award-info":[{"award-number":["Technological Center of Excellence"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["IMPACT (FB210024)."],"award-info":[{"award-number":["IMPACT (FB210024)."]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["postdoctorado 3220204"],"award-info":[{"award-number":["postdoctorado 3220204"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["Fondecyt regular 1211353"],"award-info":[{"award-number":["Fondecyt regular 1211353"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mitochondrial dysfunction is reiteratively involved in the pathogenesis of diverse neurodegenerative diseases. Current in vitro and in vivo approaches support that mitochondrial dysfunction is branded by several molecular and cellular defects, whose impact at different levels including the calcium and iron homeostasis, energetic balance and\/or oxidative stress, makes it difficult to resolve them collectively given their multifactorial nature. Mitochondrial transfer offers an overall solution since it contains the replacement of damage mitochondria by healthy units. Therefore, this review provides an introducing view on the structure and energy-related functions of mitochondria as well as their dynamics. In turn, we summarize current knowledge on how these features are deregulated in different neurodegenerative diseases, including frontotemporal dementia, multiple sclerosis, amyotrophic lateral sclerosis, Friedreich ataxia, Alzheimer\u00b4s disease, Parkinson\u00b4s disease, and Huntington\u2019s disease. Finally, we analyzed current advances in mitochondrial transfer between diverse cell types that actively participate in neurodegenerative processes, and how they might be projected toward developing novel therapeutic strategies.<\/jats:p>","DOI":"10.1186\/s12967-023-04493-w","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T12:02:09Z","timestamp":1694260929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":199,"title":["Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells"],"prefix":"10.1186","volume":"21","author":[{"given":"Felipe A.","family":"Bustamante-Barrientos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noymar","family":"Luque-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Lara-Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javiera","family":"de Solminihac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Pradenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeimi","family":"Herrera-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yildy","family":"Utreras-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Elizondo-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Vega-Letter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0067-7743","authenticated-orcid":false,"given":"Patricia","family":"Luz-Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,9]]},"reference":[{"key":"4493_CR1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-biochem-060815-014352","volume":"86","author":"N Wiedemann","year":"2017","unstructured":"Wiedemann N, Pfanner N. Mitochondrial machineries for protein import and assembly. Annu Rev Biochem. 2017;86:685\u2013714.","journal-title":"Annu Rev Biochem"},{"key":"4493_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bj.2017.12.001","volume":"41","author":"R Guo","year":"2018","unstructured":"Guo R, Gu J, Zong S, Wu M, Yang M. Structure and mechanism of mitochondrial electron transport chain. Biomed J. 2018;41:9\u201320.","journal-title":"Biomed J"},{"key":"4493_CR3","doi-asserted-by":"crossref","first-page":"107989","DOI":"10.1016\/j.celrep.2020.107989","volume":"32","author":"S Li","year":"2020","unstructured":"Li S, Wu Z, Li Y, Tantray I, De Stefani D, Mattarei A, Krishnan G, Gao FB, Vogel H, Lu B. Altered MICOS morphology and mitochondrial ion homeostasis contribute to poly(GR) toxicity associated with C9-ALS\/FTD. Cell Rep. 2020;32:107989.","journal-title":"Cell Rep"},{"key":"4493_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.freeradbiomed.2019.09.025","volume":"145","author":"RQ Xue","year":"2019","unstructured":"Xue RQ, Zhao M, Wu Q, Yang S, Cui YL, Yu XJ, Liu J, Zang WJ. Regulation of mitochondrial cristae remodelling by acetylcholine alleviates palmitate-induced cardiomyocyte hypertrophy. Free Radic Biol Med. 2019;145:103\u201317.","journal-title":"Free Radic Biol Med"},{"key":"4493_CR5","doi-asserted-by":"crossref","first-page":"210002","DOI":"10.1098\/rsob.210002","volume":"11","author":"R Edwards","year":"2021","unstructured":"Edwards R, Eaglesfield R, Tokatlidis K. The mitochondrial intermembrane space: the most constricted mitochondrial sub-compartment with the largest variety of protein import pathways. Open Biol. 2021;11:210002.","journal-title":"Open Biol"},{"key":"4493_CR6","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171492","author":"V Larosa","year":"2018","unstructured":"Larosa V, Remacle C. Insights into the respiratory chain and oxidative stress. 2018. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20171492."},{"key":"4493_CR7","volume-title":"The cell: a molecular approach","author":"GM Cooper","year":"2000","unstructured":"Cooper GM. The cell: a molecular approach. Sunderland: ASM Press; Sinauer Associates; 2000."},{"key":"4493_CR8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/bit.25492","volume":"112","author":"S Nath","year":"2015","unstructured":"Nath S, Villadsen J. Oxidative phosphorylation revisited. Biotechnol Bioeng. 2015;112:429\u201337.","journal-title":"Biotechnol Bioeng"},{"key":"4493_CR9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1146\/annurev.biochem.66.1.717","volume":"66","author":"PD Boyer","year":"1997","unstructured":"Boyer PD. The ATP synthase\u2014a splendid molecular machine. Annu Rev Biochem. 1997;66:717\u201349.","journal-title":"Annu Rev Biochem"},{"key":"4493_CR10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/EBC20170104","volume":"62","author":"L Tilokani","year":"2018","unstructured":"Tilokani L, Nagashima S, Paupe V, Prudent J. Mitochondrial dynamics: overview of molecular mechanisms. Essays Biochem. 2018;62:341\u201360.","journal-title":"Essays Biochem"},{"key":"4493_CR11","doi-asserted-by":"crossref","first-page":"106101","DOI":"10.1016\/j.biocel.2021.106101","volume":"141","author":"I Hemel","year":"2021","unstructured":"Hemel I, Sarantidou R, Gerards M. It takes two to tango: the essential role of ER-mitochondrial contact sites in mitochondrial dynamics. Int J Biochem Cell Biol. 2021;141:106101.","journal-title":"Int J Biochem Cell Biol"},{"key":"4493_CR12","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899748","author":"R Yu","year":"2019","unstructured":"Yu R, Jin SB, Lendahl U, Nister M, Zhao J. Human Fis1 regulates mitochondrial dynamics through inhibition of the fusion machinery. EMBO J. 2019. https:\/\/doi.org\/10.15252\/embj.201899748.","journal-title":"EMBO J"},{"key":"4493_CR13","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16629.1","author":"MM Cohen","year":"2018","unstructured":"Cohen MM, Tareste D. Recent insights into the structure and function of Mitofusins in mitochondrial fusion. F1000Res. 2018. https:\/\/doi.org\/10.12688\/f1000research.16629.1.","journal-title":"F1000Res"},{"key":"4493_CR14","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/cdd.2015.86","volume":"22","author":"K Palikaras","year":"2015","unstructured":"Palikaras K, Lionaki E, Tavernarakis N. Balancing mitochondrial biogenesis and mitophagy to maintain energy metabolism homeostasis. Cell Death Differ. 2015;22:1399\u2013401.","journal-title":"Cell Death Differ"},{"key":"4493_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/cdd.2012.81","volume":"20","author":"G Ashrafi","year":"2013","unstructured":"Ashrafi G, Schwarz TL. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2013;20:31\u201342.","journal-title":"Cell Death Differ"},{"key":"4493_CR16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/cns.13140","volume":"25","author":"Y Wang","year":"2019","unstructured":"Wang Y, Liu N, Lu B. Mechanisms and roles of mitophagy in neurodegenerative diseases. CNS Neurosci Ther. 2019;25:859\u201375.","journal-title":"CNS Neurosci Ther"},{"key":"4493_CR17","doi-asserted-by":"crossref","first-page":"129972","DOI":"10.1016\/j.bbagen.2021.129972","volume":"1865","author":"K Yamano","year":"2021","unstructured":"Yamano K, Kojima W. Molecular functions of autophagy adaptors upon ubiquitin-driven mitophagy. Biochim Biophys Acta Gen Subj. 2021;1865:129972.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"4493_CR18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4161\/auto.36098","volume":"11","author":"WC Shen","year":"2015","unstructured":"Shen WC, Li HY, Chen GC, Chern Y, Tu PH. Mutations in the ubiquitin-binding domain of OPTN\/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism. Autophagy. 2015;11:685\u2013700.","journal-title":"Autophagy"},{"key":"4493_CR19","doi-asserted-by":"crossref","first-page":"04","DOI":"10.3389\/fnagi.2018.00004","volume":"10","author":"MS Uddin","year":"2018","unstructured":"Uddin MS, Stachowiak A, Mamun AA, Tzvetkov NT, Takeda S, Atanasov AG, Bergantin LB, Abdel-Daim MM, Stankiewicz AM. Autophagy and Alzheimer\u2019s Disease: from molecular mechanisms to therapeutic implications. Front Aging Neurosci. 2018;10:04.","journal-title":"Front Aging Neurosci"},{"key":"4493_CR20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pneurobio.2004.10.001","volume":"74","author":"FM de Vrij","year":"2004","unstructured":"de Vrij FM, Fischer DF, van Leeuwen FW, Hol EM. Protein quality control in Alzheimer\u2019s disease by the ubiquitin proteasome system. Prog Neurobiol. 2004;74:249\u201370.","journal-title":"Prog Neurobiol"},{"key":"4493_CR21","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/ijms21031094","volume":"21","author":"A Balupuri","year":"2020","unstructured":"Balupuri A, Choi KE, Kang NS. Aggregation mechanism of Alzheimer\u2019s Amyloid beta-peptide mediated by alpha-strand\/alpha-sheet structure. Int J Mol Sci. 2020;21:1094.","journal-title":"Int J Mol Sci"},{"key":"4493_CR22","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.2174\/1381612826666200414164038","volume":"26","author":"KLC Monteiro","year":"2020","unstructured":"Monteiro KLC, Alcantara M, de Aquino TM, da Silva-Junior EF. Tau protein aggregation in Alzheimer\u2019s Disease: recent advances in the development of novel therapeutic agents. Curr Pharm Des. 2020;26:1682\u201392.","journal-title":"Curr Pharm Des"},{"key":"4493_CR23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4103\/1673-5374.230276","volume":"13","author":"J Marsh","year":"2018","unstructured":"Marsh J, Alifragis P. Synaptic dysfunction in Alzheimer\u2019s disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention. Neural Regen Res. 2018;13:616\u201323.","journal-title":"Neural Regen Res"},{"key":"4493_CR24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainres.2014.05.052","volume":"1584","author":"PE Ash","year":"2014","unstructured":"Ash PE, Vanderweyde TE, Youmans KL, Apicco DJ, Wolozin B. Pathological stress granules in Alzheimer\u2019s disease. Brain Res. 2014;1584:52\u20138.","journal-title":"Brain Res"},{"key":"4493_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2011.12.057","volume":"51","author":"JE Selfridge","year":"2013","unstructured":"Selfridge JE, Lezi E, Jianghua L, Russell HS. Role of mitochondrial homeostasis and dynamics in Alzheimer\u2019s disease. Neurobiol Dis. 2013;51:3\u201312.","journal-title":"Neurobiol Dis"},{"key":"4493_CR26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbadis.2009.08.010","volume":"1802","author":"GE Gibson","year":"2010","unstructured":"Gibson GE, Starkov A, Blass JP, Ratan RR, Beal MF. Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta. 2010;1802:122\u201334.","journal-title":"Biochim Biophys Acta"},{"key":"4493_CR27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cmet.2013.03.002","volume":"17","author":"M Liesa","year":"2013","unstructured":"Liesa M, Shirihai OS. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 2013;17:491\u2013506.","journal-title":"Cell Metab"},{"key":"4493_CR28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000446586","volume":"7","author":"DM Niyazov","year":"2016","unstructured":"Niyazov DM, Kahler SG, Frye RE. Primary mitochondrial disease and secondary mitochondrial dysfunction: importance of distinction for diagnosis and treatment. Mol Syndromol. 2016;7:122\u201337.","journal-title":"Mol Syndromol"},{"key":"4493_CR29","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer\u2019s disease. Nat Rev Dis Primers. 2015;1:15056.","journal-title":"Nat Rev Dis Primers"},{"key":"4493_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25245789","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R. Comprehensive review on Alzheimer\u2019s Disease: causes and treatment. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25245789.","journal-title":"Molecules"},{"key":"4493_CR31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cercor\/bhn113","volume":"19","author":"BC Dickerson","year":"2009","unstructured":"Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, et al. The cortical signature of Alzheimer\u2019s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009;19:497\u2013510.","journal-title":"Cereb Cortex"},{"key":"4493_CR32","first-page":"892","volume":"44","author":"M Khanahmadi","year":"2015","unstructured":"Khanahmadi M, Farhud DD, Malmir M. Genetic of Alzheimer\u2019s Disease: a narrative review article. Iran J Public Health. 2015;44:892\u2013901.","journal-title":"Iran J Public Health"},{"key":"4493_CR33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/00207454.2016.1155572","volume":"127","author":"M Yusufov","year":"2017","unstructured":"Yusufov M, Weyandt LL, Piryatinsky I. Alzheimer\u2019s disease and diet: a systematic review. Int J Neurosci. 2017;127:161\u201375.","journal-title":"Int J Neurosci"},{"key":"4493_CR34","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1017\/S1041610211001906","volume":"23","author":"M Ganguli","year":"2011","unstructured":"Ganguli M, Rodriguez E. Age, Alzheimer\u2019s disease, and the big picture. Int Psychogeriatr. 2011;23:1531\u20134.","journal-title":"Int Psychogeriatr"},{"key":"4493_CR35","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3233\/JAD-170585","volume":"62","author":"RH Swerdlow","year":"2018","unstructured":"Swerdlow RH. Mitochondria and mitochondrial cascades in Alzheimer\u2019s Disease. J Alzheimers Dis. 2018;62:1403\u201316.","journal-title":"J Alzheimers Dis"},{"key":"4493_CR36","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.40.8.1302","volume":"40","author":"WD Parker Jr","year":"1990","unstructured":"Parker WD Jr, Filley CM, Parks JK. Cytochrome oxidase deficiency in Alzheimer\u2019s disease. Neurology. 1990;40:1302\u20133.","journal-title":"Neurology"},{"key":"4493_CR37","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneur.1988.00520320022009","volume":"45","author":"GE Gibson","year":"1988","unstructured":"Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, Harding B, Perrino P. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer\u2019s disease. Arch Neurol. 1988;45:836\u201340.","journal-title":"Arch Neurol"},{"key":"4493_CR38","doi-asserted-by":"crossref","first-page":"13623","DOI":"10.1016\/S0021-9258(17)36875-8","volume":"269","author":"D Gabuzda","year":"1994","unstructured":"Gabuzda D, Busciglio J, Chen LB, Matsudaira P, Yankner BA. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem. 1994;269:13623\u20138.","journal-title":"J Biol Chem"},{"key":"4493_CR39","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1089\/ars.2011.4173","volume":"16","author":"K Leuner","year":"2012","unstructured":"Leuner K, Schutt T, Kurz C, Eckert SH, Schiller C, Occhipinti A, Mai S, Jendrach M, Eckert GP, Kruse SE, et al. Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal. 2012;16:1421\u201333.","journal-title":"Antioxid Redox Signal"},{"key":"4493_CR40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00005072-197004000-00001","volume":"29","author":"H Wisniewski","year":"1970","unstructured":"Wisniewski H, Terry RD, Hirano A. Neurofibrillary pathology. J Neuropathol Exp Neurol. 1970;29:163\u201376.","journal-title":"J Neuropathol Exp Neurol"},{"key":"4493_CR41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00005072-197007000-00009","volume":"29","author":"AB Johnson","year":"1970","unstructured":"Johnson AB, Blum NR. Nucleoside phosphatase activities associated with the tangles and plaques of alzheimer\u2019s disease: a histochemical study of natural and experimental neurofibrillary tangles. J Neuropathol Exp Neurol. 1970;29:463\u201378.","journal-title":"J Neuropathol Exp Neurol"},{"key":"4493_CR42","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00004728-198308000-00003","volume":"7","author":"RP Friedland","year":"1983","unstructured":"Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Huesman RH, Derenzo SE. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr. 1983;7:590\u20138.","journal-title":"J Comput Assist Tomogr"},{"key":"4493_CR43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0006-8993(87)91553-8","volume":"436","author":"NR Sims","year":"1987","unstructured":"Sims NR, Finegan JM, Blass JP, Bowen DM, Neary D. Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res. 1987;436:30\u20138.","journal-title":"Brain Res"},{"key":"4493_CR44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.redox.2014.03.006","volume":"2","author":"HM Wilkins","year":"2014","unstructured":"Wilkins HM, Carl SM, Swerdlow RH. Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies. Redox Biol. 2014;2:619\u201331.","journal-title":"Redox Biol"},{"key":"4493_CR45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7","volume":"48","author":"SM Khan","year":"2000","unstructured":"Khan SM, Cassarino DS, Abramova NN, Keeney PM, Borland MK, Trimmer PA, Krebs CT, Bennett JC, Parks JK, Swerdlow RH, et al. Alzheimer\u2019s disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Ann Neurol. 2000;48:148\u201355.","journal-title":"Ann Neurol"},{"key":"4493_CR46","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1471-4159.2005.03493.x","volume":"95","author":"GU Hoglinger","year":"2005","unstructured":"Hoglinger GU, Lannuzel A, Khondiker ME, Michel PP, Duyckaerts C, Feger J, Champy P, Prigent A, Medja F, Lombes A, et al. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem. 2005;95:930\u20139.","journal-title":"J Neurochem"},{"key":"4493_CR47","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1523\/JNEUROSCI.1644-07.2007","volume":"27","author":"M Escobar-Khondiker","year":"2007","unstructured":"Escobar-Khondiker M, Hollerhage M, Muriel MP, Champy P, Bach A, Depienne C, Respondek G, Yamada ES, Lannuzel A, Yagi T, et al. Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. J Neurosci. 2007;27:7827\u201337.","journal-title":"J Neurosci"},{"key":"4493_CR48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1326-9-16","volume":"9","author":"L Kukreja","year":"2014","unstructured":"Kukreja L, Kujoth GC, Prolla TA, Van Leuven F, Vassar R. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP\/Ld transgenic mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2014;9:16.","journal-title":"Mol Neurodegener"},{"key":"4493_CR49","doi-asserted-by":"crossref","first-page":"14163","DOI":"10.1073\/pnas.0705738104","volume":"104","author":"H Fukui","year":"2007","unstructured":"Fukui H, Diaz F, Garcia S, Moraes CT. Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2007;104:14163\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4493_CR50","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.neurobiolaging.2013.04.014","volume":"34","author":"M Pinto","year":"2013","unstructured":"Pinto M, Pickrell AM, Fukui H, Moraes CT. Mitochondrial DNA damage in a mouse model of Alzheimer\u2019s disease decreases amyloid beta plaque formation. Neurobiol Aging. 2013;34:2399\u2013407.","journal-title":"Neurobiol Aging"},{"key":"4493_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050488","author":"PH Reddy","year":"2019","unstructured":"Reddy PH, Oliver DM. Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer\u2019s Disease. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8050488.","journal-title":"Cells"},{"key":"4493_CR52","doi-asserted-by":"crossref","first-page":"e21776","DOI":"10.7554\/eLife.21776","volume":"6","author":"P Tammineni","year":"2017","unstructured":"Tammineni P, Ye X, Feng T, Aikal D, Cai Q. Impaired retrograde transport of axonal autophagosomes contributes to autophagic stress in Alzheimer\u2019s disease neurons. Elife. 2017;6:e21776.","journal-title":"Elife"},{"key":"4493_CR53","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrm.2016.14","volume":"17","author":"EF Fang","year":"2016","unstructured":"Fang EF, Scheibye-Knudsen M, Chua KF, Mattson MP, Croteau DL, Bohr VA. Nuclear DNA damage signalling to mitochondria in ageing. Nat Rev Mol Cell Biol. 2016;17:308\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4493_CR54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fnana.2018.00113","volume":"12","author":"NL Del Rey","year":"2018","unstructured":"Del Rey NL, Quiroga-Varela A, Garbayo E, Carballo-Carbajal I, Fernandez-Santiago R, Monje MHG, Trigo-Damas I, Blanco-Prieto MJ, Blesa J. Advances in Parkinson\u2019s Disease: 200 years later. Front Neuroanat. 2018;12:113.","journal-title":"Front Neuroanat"},{"key":"4493_CR55","doi-asserted-by":"crossref","first-page":"a008862","DOI":"10.1101\/cshperspect.a008862","volume":"1","author":"CG Goetz","year":"2011","unstructured":"Goetz CG. The history of Parkinson\u2019s disease: early clinical descriptions and neurological therapies. Cold Spring Harb Perspect Med. 2011;1:a008862.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4493_CR56","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/practneurol-2013-000741","volume":"14","author":"A Todorova","year":"2014","unstructured":"Todorova A, Jenner P, Ray Chaudhuri K. Non-motor Parkinson\u2019s: integral to motor Parkinson\u2019s, yet often neglected. Pract Neurol. 2014;14:310\u201322.","journal-title":"Pract Neurol"},{"key":"4493_CR57","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1212\/01.WNL.0000036610.36834.E0","volume":"59","author":"G Levy","year":"2002","unstructured":"Levy G, Tang MX, Louis ED, Cote LJ, Alfaro B, Mejia H, Stern Y, Marder K. The association of incident dementia with mortality in PD. Neurology. 2002;59:1708\u201313.","journal-title":"Neurology"},{"key":"4493_CR58","doi-asserted-by":"crossref","first-page":"37060","DOI":"10.1007\/s11356-021-14619-6","volume":"28","author":"I Kaur","year":"2021","unstructured":"Kaur I, Behl T, Sehgal A, Singh S, Sharma N, Aleya L, Bungau S. Connecting the dots between mitochondrial dysfunction and Parkinson\u2019s disorder: focus mitochondria-targeting therapeutic paradigm in mitigating the disease severity. Environ Sci Pollut Res Int. 2021;28:37060\u201381.","journal-title":"Environ Sci Pollut Res Int"},{"key":"4493_CR59","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1042\/EBC20170023","volume":"61","author":"C Karabiyik","year":"2017","unstructured":"Karabiyik C, Lee MJ, Rubinsztein DC. Autophagy impairment in Parkinson\u2019s disease. Essays Biochem. 2017;61:711\u201320.","journal-title":"Essays Biochem"},{"key":"4493_CR60","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1042\/BST20170501","volume":"46","author":"R Macdonald","year":"2018","unstructured":"Macdonald R, Barnes K, Hastings C, Mortiboys H. Mitochondrial abnormalities in Parkinson\u2019s disease and Alzheimer\u2019s disease: can mitochondria be targeted therapeutically? Biochem Soc Trans. 2018;46:891\u2013909.","journal-title":"Biochem Soc Trans"},{"key":"4493_CR61","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.35.7.949","volume":"35","author":"PA Ballard","year":"1985","unstructured":"Ballard PA, Tetrud JW, Langston JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology. 1985;35:949\u201356.","journal-title":"Neurology"},{"key":"4493_CR62","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.3390\/ijms18122507","volume":"18","author":"T Chen","year":"2017","unstructured":"Chen T, Tan J, Wan Z, Zou Y, Afewerky HK, Zhang Z, Zhang T. Effects of commonly used pesticides in China on the mitochondria and ubiquitin-proteasome system in Parkinson\u2019s Disease. Int J Mol Sci. 2017;18:2507.","journal-title":"Int J Mol Sci"},{"key":"4493_CR63","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","volume":"2","author":"J Bove","year":"2005","unstructured":"Bove J, Prou D, Perier C, Przedborski S. Toxin-induced models of Parkinson\u2019s disease. NeuroRx. 2005;2:484\u201394.","journal-title":"NeuroRx"},{"key":"4493_CR64","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1089\/ars.2011.4033","volume":"16","author":"TN Martinez","year":"2012","unstructured":"Martinez TN, Greenamyre JT. Toxin models of mitochondrial dysfunction in Parkinson\u2019s disease. Antioxid Redox Signal. 2012;16:920\u201334.","journal-title":"Antioxid Redox Signal"},{"key":"4493_CR65","doi-asserted-by":"crossref","first-page":"114617","DOI":"10.1016\/j.taap.2019.114617","volume":"378","author":"J Ren","year":"2019","unstructured":"Ren J, Yuan L, Wang W, Zhang M, Wang Q, Li S, Zhang L, Hu K. Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson\u2019s disease model by activating Nrf2\/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway. Toxicol Appl Pharmacol. 2019;378:114617.","journal-title":"Toxicol Appl Pharmacol"},{"key":"4493_CR66","doi-asserted-by":"crossref","first-page":"a009316","DOI":"10.1101\/cshperspect.a009316","volume":"1","author":"K Tieu","year":"2011","unstructured":"Tieu K. A guide to neurotoxic animal models of Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2011;1:a009316.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4493_CR67","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AH Schapira","year":"1990","unstructured":"Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem. 1990;54:823\u20137.","journal-title":"J Neurochem"},{"key":"4493_CR68","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","volume":"1189","author":"WD Parker Jr","year":"2008","unstructured":"Parker WD Jr, Parks JK, Swerdlow RH. Complex I deficiency in Parkinson\u2019s disease frontal cortex. Brain Res. 2008;1189:215\u20138.","journal-title":"Brain Res"},{"key":"4493_CR69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/15216540152845939","volume":"52","author":"JT Greenamyre","year":"2001","unstructured":"Greenamyre JT, Sherer TB, Betarbet R, Panov AV. Complex I and Parkinson\u2019s disease. IUBMB Life. 2001;52:135\u201341.","journal-title":"IUBMB Life"},{"key":"4493_CR70","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/elps.11501601125","volume":"16","author":"H Schagger","year":"1995","unstructured":"Schagger H. Quantification of oxidative phosphorylation enzymes after blue native electrophoresis and two-dimensional resolution: normal complex I protein amounts in Parkinson\u2019s disease conflict with reduced catalytic activities. Electrophoresis. 1995;16:763\u201370.","journal-title":"Electrophoresis"},{"key":"4493_CR71","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.nbd.2014.06.014","volume":"70","author":"LH Sanders","year":"2014","unstructured":"Sanders LH, McCoy J, Hu X, Mastroberardino PG, Dickinson BC, Chang CJ, Chu CT, Van Houten B, Greenamyre JT. Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson\u2019s disease. Neurobiol Dis. 2014;70:214\u201323.","journal-title":"Neurobiol Dis"},{"key":"4493_CR72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2009.11.065","volume":"469","author":"C Isobe","year":"2010","unstructured":"Isobe C, Abe T, Terayama Y. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2\u2019-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson\u2019s disease demonstrate that mitochondrial oxidative damage and\/or oxidative DNA damage contributes to the neurodegenerative process. Neurosci Lett. 2010;469:159\u201363.","journal-title":"Neurosci Lett"},{"key":"4493_CR73","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","volume":"38","author":"A Bender","year":"2006","unstructured":"Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 2006;38:515\u20137.","journal-title":"Nat Genet"},{"key":"4493_CR74","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajhg.2007.09.018","volume":"82","author":"AK Reeve","year":"2008","unstructured":"Reeve AK, Krishnan KJ, Elson JL, Morris CM, Bender A, Lightowlers RN, Turnbull DM. Nature of mitochondrial DNA deletions in substantia nigra neurons. Am J Hum Genet. 2008;82:228\u201335.","journal-title":"Am J Hum Genet"},{"key":"4493_CR75","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1172\/JCI43871","volume":"121","author":"H She","year":"2011","unstructured":"She H, Yang Q, Shepherd K, Smith Y, Miller G, Testa C, Mao Z. Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients. J Clin Invest. 2011;121:930\u201340.","journal-title":"J Clin Invest"},{"key":"4493_CR76","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ana.410400417","volume":"40","author":"RH Swerdlow","year":"1996","unstructured":"Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, Bennett JP Jr, Davis RE, Parker WD Jr. Origin and functional consequences of the complex I defect in Parkinson\u2019s disease. Ann Neurol. 1996;40:663\u201371.","journal-title":"Ann Neurol"},{"key":"4493_CR77","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1212\/WNL.0000000000001905","volume":"85","author":"H Mortiboys","year":"2015","unstructured":"Mortiboys H, Furmston R, Bronstad G, Aasly J, Elliott C, Bandmann O. UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2(G2019S) carriers and in vivo. Neurology. 2015;85:846\u201352.","journal-title":"Neurology"},{"key":"4493_CR78","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nbd.2015.02.031","volume":"78","author":"M Yue","year":"2015","unstructured":"Yue M, Hinkle KM, Davies P, Trushina E, Fiesel FC, Christenson TA, Schroeder AS, Zhang L, Bowles E, Behrouz B, et al. Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice. Neurobiol Dis. 2015;78:172\u201395.","journal-title":"Neurobiol Dis"},{"key":"4493_CR79","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ana.21492","volume":"64","author":"H Mortiboys","year":"2008","unstructured":"Mortiboys H, Thomas KJ, Koopman WJ, Klaffke S, Abou-Sleiman P, Olpin S, Wood NW, Willems PH, Smeitink JA, Cookson MR, Bandmann O. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol. 2008;64:555\u201365.","journal-title":"Ann Neurol"},{"key":"4493_CR80","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1073\/pnas.0737556100","volume":"100","author":"JC Greene","year":"2003","unstructured":"Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci U S A. 2003;100:4078\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4493_CR81","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/brain\/awp108","volume":"132","author":"L Flinn","year":"2009","unstructured":"Flinn L, Mortiboys H, Volkmann K, Koster RW, Ingham PW, Bandmann O. Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain. 2009;132:1613\u201323.","journal-title":"Brain"},{"key":"4493_CR82","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ana.23999","volume":"74","author":"LJ Flinn","year":"2013","unstructured":"Flinn LJ, Keatinge M, Bretaud S, Mortiboys H, Matsui H, De Felice E, Woodroof HI, Brown L, McTighe A, Soellner R, et al. TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency. Ann Neurol. 2013;74:837\u201347.","journal-title":"Ann Neurol"},{"key":"4493_CR83","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/prca.201600005","volume":"10","author":"KL Stauch","year":"2016","unstructured":"Stauch KL, Villeneuve LM, Purnell PR, Ottemann BM, Emanuel K, Fox HS. Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II-mediated respiration. Proteomics Clin Appl. 2016;10:1205\u201317.","journal-title":"Proteomics Clin Appl"},{"key":"4493_CR84","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"JM Lee","year":"2012","unstructured":"Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 2012;78:690\u20135.","journal-title":"Neurology"},{"key":"4493_CR85","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M. Huntington disease. J Neuropathol Exp Neurol. 1998;57:369\u201384.","journal-title":"J Neuropathol Exp Neurol"},{"key":"4493_CR86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ. Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011;10:83\u201398.","journal-title":"Lancet Neurol"},{"key":"4493_CR87","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/hmg\/ddr195","volume":"20","author":"JC Jacobsen","year":"2011","unstructured":"Jacobsen JC, Gregory GC, Woda JM, Thompson MN, Coser KR, Murthy V, Kohane IS, Gusella JF, Seong IS, MacDonald ME, et al. HD CAG-correlated gene expression changes support a simple dominant gain of function. Hum Mol Genet. 2011;20:2846\u201360.","journal-title":"Hum Mol Genet"},{"key":"4493_CR88","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/hmg\/ddx394","volume":"27","author":"DE Ehrnhoefer","year":"2018","unstructured":"Ehrnhoefer DE, Southwell AL, Sivasubramanian M, Qiu X, Villanueva EB, Xie Y, Waltl S, Anderson L, Fazeli A, Casal L, et al. HACE1 is essential for astrocyte mitochondrial function and influences Huntington disease phenotypes in vivo. Hum Mol Genet. 2018;27:239\u201353.","journal-title":"Hum Mol Genet"},{"key":"4493_CR89","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/ars.2012.4928","volume":"19","author":"F Haun","year":"2013","unstructured":"Haun F, Nakamura T, Shiu AD, Cho DH, Tsunemi T, Holland EA, La Spada AR, Lipton SA. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington\u2019s disease. Antioxid Redox Signal. 2013;19:1173\u201384.","journal-title":"Antioxid Redox Signal"},{"key":"4493_CR90","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuint.2017.01.001","volume":"109","author":"J Hamilton","year":"2017","unstructured":"Hamilton J, Brustovetsky T, Brustovetsky N. Oxidative metabolism and Ca(2+) handling in striatal mitochondria from YAC128 mice, a model of Huntington\u2019s disease. Neurochem Int. 2017;109:24\u201333.","journal-title":"Neurochem Int"},{"key":"4493_CR91","first-page":"2762","volume":"25","author":"J Hamilton","year":"2016","unstructured":"Hamilton J, Pellman JJ, Brustovetsky T, Harris RA, Brustovetsky N. Oxidative metabolism and Ca2+ handling in isolated brain mitochondria and striatal neurons from R6\/2 mice, a model of Huntington\u2019s disease. Hum Mol Genet. 2016;25:2762\u201375.","journal-title":"Hum Mol Genet"},{"key":"4493_CR92","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/hmg\/ddy430","volume":"29","author":"Consortium HDi","year":"2020","unstructured":"Consortium HDi. Bioenergetic deficits in Huntington\u2019s disease iPSC-derived neural cells and rescue with glycolytic metabolites. Hum Mol Genet. 2020;29:1757\u201371.","journal-title":"Hum Mol Genet"},{"key":"4493_CR93","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/1028415X.2016.1237074","volume":"21","author":"M Orozco-Ibarra","year":"2018","unstructured":"Orozco-Ibarra M, Garcia-Morales J, Calvo-Silva FJ, Fernandez-Valverde F, Serrano-Garcia N. Striatal mitochondria response to 3-nitropropionic acid and fish oil treatment. Nutr Neurosci. 2018;21:132\u201342.","journal-title":"Nutr Neurosci"},{"key":"4493_CR94","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/hmg\/ddw045","volume":"25","author":"X Yin","year":"2016","unstructured":"Yin X, Manczak M, Reddy PH. Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington\u2019s disease. Hum Mol Genet. 2016;25:1739\u201353.","journal-title":"Hum Mol Genet"},{"key":"4493_CR95","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1093\/hmg\/ddv429","volume":"24","author":"M Manczak","year":"2015","unstructured":"Manczak M, Reddy PH. Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington\u2019s disease. Hum Mol Genet. 2015;24:7308\u201325.","journal-title":"Hum Mol Genet"},{"key":"4493_CR96","doi-asserted-by":"crossref","first-page":"104741","DOI":"10.1016\/j.nbd.2020.104741","volume":"136","author":"M Cherubini","year":"2020","unstructured":"Cherubini M, Lopez-Molina L, Gines S. Mitochondrial fission in Huntington\u2019s disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca(2+) efflux and Reactive Oxygen Species (ROS) homeostasis. Neurobiol Dis. 2020;136:104741.","journal-title":"Neurobiol Dis"},{"key":"4493_CR97","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.freeradbiomed.2019.11.021","volume":"146","author":"BR Pinho","year":"2020","unstructured":"Pinho BR, Duarte AI, Canas PM, Moreira PI, Murphy MP, Oliveira JMA. The interplay between redox signalling and proteostasis in neurodegeneration: in vivo effects of a mitochondria-targeted antioxidant in Huntington\u2019s disease mice. Free Radic Biol Med. 2020;146:372\u201382.","journal-title":"Free Radic Biol Med"},{"key":"4493_CR98","doi-asserted-by":"crossref","first-page":"12646","DOI":"10.1038\/ncomms12646","volume":"7","author":"X Guo","year":"2016","unstructured":"Guo X, Sun X, Hu D, Wang YJ, Fujioka H, Vyas R, Chakrapani S, Joshi AU, Luo Y, Mochly-Rosen D, Qi X. VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington\u2019s disease. Nat Commun. 2016;7:12646.","journal-title":"Nat Commun"},{"key":"4493_CR99","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2018.04.002","volume":"120","author":"S Agrawal","year":"2018","unstructured":"Agrawal S, Fox J, Thyagarajan B, Fox JH. Brain mitochondrial iron accumulates in Huntington\u2019s disease, mediates mitochondrial dysfunction, and can be removed pharmacologically. Free Radic Biol Med. 2018;120:317\u201329.","journal-title":"Free Radic Biol Med"},{"key":"4493_CR100","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn1971","volume":"7","author":"P Pasinelli","year":"2006","unstructured":"Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci. 2006;7:710\u201323.","journal-title":"Nat Rev Neurosci"},{"key":"4493_CR101","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1212\/WNL.0000000000004109","volume":"89","author":"SB Gibson","year":"2017","unstructured":"Gibson SB, Downie JM, Tsetsou S, Feusier JE, Figueroa KP, Bromberg MB, Jorde LB, Pulst SM. The evolving genetic risk for sporadic ALS. Neurology. 2017;89:226\u201333.","journal-title":"Neurology"},{"key":"4493_CR102","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.1073\/pnas.0402026101","volume":"101","author":"L Dupuis","year":"2004","unstructured":"Dupuis L, Oudart H, Rene F, de Aguilar JLG, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A. 2004;101:11159\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4493_CR103","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ajcn\/74.3.328","volume":"74","author":"JC Desport","year":"2001","unstructured":"Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, Couratier P. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74:328\u201334.","journal-title":"Am J Clin Nutr"},{"key":"4493_CR104","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41593-019-0397-0","volume":"22","author":"SY Choi","year":"2019","unstructured":"Choi SY, Lopez-Gonzalez R, Krishnan G, Phillips HL, Li AN, Seeley WW, Yao WD, Almeida S, Gao FB. C9ORF72-ALS\/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat Neurosci. 2019;22:851\u201362.","journal-title":"Nat Neurosci"},{"key":"4493_CR105","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/brain\/awu138","volume":"137","author":"S Bannwarth","year":"2014","unstructured":"Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, Berg-Alonso L, Kageyama Y, Serre V, Moore DG, et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137:2329\u201345.","journal-title":"Brain"},{"key":"4493_CR106","doi-asserted-by":"crossref","first-page":"103396","DOI":"10.1016\/j.mcn.2019.103396","volume":"100","author":"J Gao","year":"2019","unstructured":"Gao J, Wang L, Yan T, Perry G, Wang X. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Mol Cell Neurosci. 2019;100:103396.","journal-title":"Mol Cell Neurosci"},{"issue":"Pt B","key":"4493_CR107","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.expneurol.2014.04.013","volume":"262","author":"CS Leblond","year":"2014","unstructured":"Leblond CS, Kaneb HM, Dion PA, Rouleau GA. Dissection of genetic factors associated with amyotrophic lateral sclerosis. Exp Neurol. 2014;262(Pt B):91\u2013101.","journal-title":"Exp Neurol"},{"key":"4493_CR108","doi-asserted-by":"crossref","first-page":"132933","DOI":"10.1016\/j.neulet.2017.06.052","volume":"710","author":"EF Smith","year":"2019","unstructured":"Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett. 2019;710:132933.","journal-title":"Neurosci Lett"},{"key":"4493_CR109","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1093\/brain\/awaa340","volume":"143","author":"M Sassani","year":"2020","unstructured":"Sassani M, Alix JJ, McDermott CJ, Baster K, Hoggard N, Wild JM, Mortiboys HJ, Shaw PJ, Wilkinson ID, Jenkins TM. Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis. Brain. 2020;143:3603\u201318.","journal-title":"Brain"},{"key":"4493_CR110","doi-asserted-by":"crossref","first-page":"132932","DOI":"10.1016\/j.neulet.2017.06.051","volume":"710","author":"D Bargiela","year":"2019","unstructured":"Bargiela D, Chinnery PF. Mitochondria in neuroinflammation\u2014multiple sclerosis (MS), leber hereditary optic neuropathy (LHON) and LHON-MS. Neurosci Lett. 2019;710:132932.","journal-title":"Neurosci Lett"},{"key":"4493_CR111","first-page":"175","volume":"37","author":"MM Goldenberg","year":"2012","unstructured":"Goldenberg MM. Multiple sclerosis review. PT. 2012;37:175\u201384.","journal-title":"PT"},{"key":"4493_CR112","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12192-019-01049-0","volume":"25","author":"C Pistono","year":"2020","unstructured":"Pistono C, Monti MC, Boiocchi C, Berzolari FG, Osera C, Mallucci G, Cuccia M, Pascale A, Montomoli C, Bergamaschi R. Response to oxidative stress of peripheral blood mononuclear cells from multiple sclerosis patients and healthy controls. Cell Stress Chaperones. 2020;25:81\u201391.","journal-title":"Cell Stress Chaperones"},{"key":"4493_CR113","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/bs.ircmb.2016.08.003","volume":"328","author":"S Patergnani","year":"2017","unstructured":"Patergnani S, Fossati V, Bonora M, Giorgi C, Marchi S, Missiroli S, Rusielewicz T, Wieckowski MR, Pinton P. Mitochondria in multiple sclerosis: molecular mechanisms of pathogenesis. Int Rev Cell Mol Biol. 2017;328:49\u2013103.","journal-title":"Int Rev Cell Mol Biol"},{"key":"4493_CR114","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/eji.201948223","volume":"49","author":"S De Biasi","year":"2019","unstructured":"De Biasi S, Simone AM, Bianchini E, Lo Tartaro D, Pecorini S, Nasi M, Patergnani S, Carnevale G, Gibellini L, Ferraro D, et al. Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients. Eur J Immunol. 2019;49:2204\u201321.","journal-title":"Eur J Immunol"},{"key":"4493_CR115","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2015.09.018","volume":"1862","author":"H Lassmann","year":"2016","unstructured":"Lassmann H, van Horssen J. Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions. Biochim Biophys Acta. 2016;1862:506\u201310.","journal-title":"Biochim Biophys Acta"},{"key":"4493_CR116","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12974-016-0788-z","volume":"14","author":"Y Haile","year":"2017","unstructured":"Haile Y, Deng X, Ortiz-Sandoval C, Tahbaz N, Janowicz A, Lu JQ, Kerr BJ, Gutowski NJ, Holley JE, Eggleton P, et al. Rab32 connects ER stress to mitochondrial defects in multiple sclerosis. J Neuroinflammation. 2017;14:19.","journal-title":"J Neuroinflammation"},{"key":"4493_CR117","doi-asserted-by":"crossref","first-page":"725370","DOI":"10.1155\/2015\/725370","volume":"2015","author":"L Haider","year":"2015","unstructured":"Haider L. Inflammation, iron, energy failure, and oxidative stress in the pathogenesis of multiple sclerosis. Oxid Med Cell Longev. 2015;2015:725370.","journal-title":"Oxid Med Cell Longev"},{"key":"4493_CR118","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1177\/1352458514544537","volume":"20","author":"GR Campbell","year":"2014","unstructured":"Campbell GR, Worrall JT, Mahad DJ. The central role of mitochondria in axonal degeneration in multiple sclerosis. Mult Scler. 2014;20:1806\u201313.","journal-title":"Mult Scler"},{"key":"4493_CR119","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/brain\/awp046","volume":"132","author":"DJ Mahad","year":"2009","unstructured":"Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS, Lassmann H, Turnbull DM. Mitochondrial changes within axons in multiple sclerosis. Brain. 2009;132:1161\u201374.","journal-title":"Brain"},{"key":"4493_CR120","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1093\/brain\/awm236","volume":"130","author":"C Marik","year":"2007","unstructured":"Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain. 2007;130:2800\u201315.","journal-title":"Brain"},{"key":"4493_CR121","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00401-020-02179-x","volume":"140","author":"S Licht-Mayer","year":"2020","unstructured":"Licht-Mayer S, Campbell GR, Canizares M, Mehta AR, Gane AB, McGill K, Ghosh A, Fullerton A, Menezes N, Dean J, et al. Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis. Acta Neuropathol. 2020;140:143\u201367.","journal-title":"Acta Neuropathol"},{"key":"4493_CR122","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/brain\/124.6.1114","volume":"124","author":"B Kornek","year":"2001","unstructured":"Kornek B, Storch MK, Bauer J, Djamshidian A, Weissert R, Wallstroem E, Stefferl A, Zimprich F, Olsson T, Linington C, et al. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain. 2001;124:1114\u201324.","journal-title":"Brain"},{"key":"4493_CR123","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbadis.2009.07.002","volume":"1802","author":"P Mao","year":"2010","unstructured":"Mao P, Reddy PH. Is multiple sclerosis a mitochondrial disease? Biochim Biophys Acta. 2010;1802:66\u201379.","journal-title":"Biochim Biophys Acta"},{"key":"4493_CR124","doi-asserted-by":"crossref","first-page":"11825","DOI":"10.1074\/jbc.M110.153049","volume":"286","author":"M Domercq","year":"2011","unstructured":"Domercq M, Alberdi E, Sanchez-Gomez MV, Ariz U, Perez-Samartin A, Matute C. Dual-specific phosphatase-6 (Dusp6) and ERK mediate AMPA receptor-induced oligodendrocyte death. J Biol Chem. 2011;286:11825\u201336.","journal-title":"J Biol Chem"},{"key":"4493_CR125","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1038\/s41467-020-17871-5","volume":"11","author":"KE Carlstrom","year":"2020","unstructured":"Carlstrom KE, Zhu K, Ewing E, Krabbendam IE, Harris RA, Falcao AM, Jagodic M, Castelo-Branco G, Piehl F. Gsta4 controls apoptosis of differentiating adult oligodendrocytes during homeostasis and remyelination via the mitochondria-associated Fas-Casp8-Bid-axis. Nat Commun. 2020;11:4071.","journal-title":"Nat Commun"},{"key":"4493_CR126","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12013-014-0006-5","volume":"70","author":"PK Kamat","year":"2014","unstructured":"Kamat PK, Kalani A, Kyles P, Tyagi SC, Tyagi N. Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease. Cell Biochem Biophys. 2014;70:707\u201319.","journal-title":"Cell Biochem Biophys"},{"key":"4493_CR127","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/15592294.2020.1735075","volume":"15","author":"NK Singhal","year":"2020","unstructured":"Singhal NK, Sternbach S, Fleming S, Alkhayer K, Shelestak J, Popescu D, Weaver A, Clements R, Wasek B, Bottiglieri T, et al. Betaine restores epigenetic control and supports neuronal mitochondria in the cuprizone mouse model of multiple sclerosis. Epigenetics. 2020;15:871\u201386.","journal-title":"Epigenetics"},{"key":"4493_CR128","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/j.1460-9568.2012.08150.x","volume":"35","author":"CM Rice","year":"2012","unstructured":"Rice CM, Sun M, Kemp K, Gray E, Wilkins A, Scolding NJ. Mitochondrial sirtuins\u2013a new therapeutic target for repair and protection in multiple sclerosis. Eur J Neurosci. 2012;35:1887\u201393.","journal-title":"Eur J Neurosci"},{"key":"4493_CR129","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","volume":"97","author":"C Baecher-Allan","year":"2018","unstructured":"Baecher-Allan C, Kaskow BJ, Weiner HL. Multiple sclerosis: mechanisms and immunotherapy. Neuron. 2018;97:742\u201368.","journal-title":"Neuron"},{"key":"4493_CR130","doi-asserted-by":"crossref","first-page":"7191080","DOI":"10.1155\/2020\/7191080","volume":"2020","author":"V Pegoretti","year":"2020","unstructured":"Pegoretti V, Swanson KA, Bethea JR, Probert L, Eisel ULM, Fischer R. Inflammation and oxidative stress in multiple sclerosis: consequences for therapy development. Oxid Med Cell Longev. 2020;2020:7191080.","journal-title":"Oxid Med Cell Longev"},{"key":"4493_CR131","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.bbadis.2013.09.005","volume":"1832","author":"P Mao","year":"2013","unstructured":"Mao P, Manczak M, Shirendeb UP, Reddy PH. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Biochim Biophys Acta. 2013;1832:2322\u201331.","journal-title":"Biochim Biophys Acta"},{"key":"4493_CR132","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.molmed.2018.07.007","volume":"24","author":"L Peruzzotti-Jametti","year":"2018","unstructured":"Peruzzotti-Jametti L, Pluchino S. Targeting mitochondrial metabolism in neuroinflammation: towards a therapy for progressive multiple sclerosis. Trends Mol Med. 2018;24:838\u201355.","journal-title":"Trends Mol Med"},{"key":"4493_CR133","doi-asserted-by":"crossref","first-page":"624746","DOI":"10.3389\/fimmu.2021.624746","volume":"12","author":"N Luque-Campos","year":"2021","unstructured":"Luque-Campos N, Bustamante-Barrientos FA, Pradenas C, Garcia C, Araya MJ, Bohaud C, Contreras-Lopez R, Elizondo-Vega R, Djouad F, Luz-Crawford P, Vega-Letter AM. The macrophage response is driven by mesenchymal stem cell-mediated metabolic reprogramming. Front Immunol. 2021;12:624746.","journal-title":"Front Immunol"},{"key":"4493_CR134","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1038\/s41467-020-17954-3","volume":"11","author":"PG Mazzara","year":"2020","unstructured":"Mazzara PG, Muggeo S, Luoni M, Massimino L, Zaghi M, Valverde PT, Brusco S, Marzi MJ, Palma C, Colasante G, et al. Frataxin gene editing rescues Friedreich\u2019s ataxia pathology in dorsal root ganglia organoid-derived sensory neurons. Nat Commun. 2020;11:4178.","journal-title":"Nat Commun"},{"key":"4493_CR135","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00429-013-0547-1","volume":"219","author":"A Zalesky","year":"2014","unstructured":"Zalesky A, Akhlaghi H, Corben LA, Bradshaw JL, Delatycki MB, Storey E, Georgiou-Karistianis N, Egan GF. Cerebello-cerebral connectivity deficits in Friedreich ataxia. Brain Struct Funct. 2014;219:969\u201381.","journal-title":"Brain Struct Funct"},{"key":"4493_CR136","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neubiorev.2017.08.006","volume":"84","author":"LP Selvadurai","year":"2018","unstructured":"Selvadurai LP, Harding IH, Corben LA, Georgiou-Karistianis N. Cerebral abnormalities in Friedreich ataxia: a review. Neurosci Biobehav Rev. 2018;84:394\u2013406.","journal-title":"Neurosci Biobehav Rev"},{"key":"4493_CR137","doi-asserted-by":"crossref","first-page":"15788","DOI":"10.1038\/s41598-020-72884-w","volume":"10","author":"L Weng","year":"2020","unstructured":"Weng L, Laboureur L, Wang Q, Guo L, Xu P, Gottlieb L, Lynch DR, Mesaros C, Blair IA. Extra-mitochondrial mouse frataxin and its implications for mouse models of Friedreich\u2019s ataxia. Sci Rep. 2020;10:15788.","journal-title":"Sci Rep"},{"key":"4493_CR138","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.freeradbiomed.2014.04.016","volume":"73","author":"E Obis","year":"2014","unstructured":"Obis E, Irazusta V, Sanchis D, Ros J, Tamarit J. Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism. Free Radic Biol Med. 2014;73:21\u201333.","journal-title":"Free Radic Biol Med"},{"key":"4493_CR139","doi-asserted-by":"crossref","first-page":"e0178354","DOI":"10.1371\/journal.pone.0178354","volume":"12","author":"AR Stram","year":"2017","unstructured":"Stram AR, Wagner GR, Fogler BD, Pride PM, Hirschey MD, Payne RM. Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich\u2019s ataxia cardiomyopathy. PLoS ONE. 2017;12:e0178354.","journal-title":"PLoS ONE"},{"key":"4493_CR140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbadis.2011.11.003","volume":"1822","author":"AL Bulteau","year":"2012","unstructured":"Bulteau AL, Planamente S, Jornea L, Dur A, Lesuisse E, Camadro JM, Auchere F. Changes in mitochondrial glutathione levels and protein thiol oxidation in yfh1 yeast cells and the lymphoblasts of patients with Friedreich\u2019s ataxia. Biochim Biophys Acta. 2012;1822:212\u201325.","journal-title":"Biochim Biophys Acta"},{"key":"4493_CR141","doi-asserted-by":"crossref","first-page":"e34600","DOI":"10.1371\/journal.pone.0034600","volume":"7","author":"TE Richardson","year":"2012","unstructured":"Richardson TE, Yu AE, Wen Y, Yang SH, Simpkins JW. Estrogen prevents oxidative damage to the mitochondria in Friedreich\u2019s ataxia skin fibroblasts. PLoS ONE. 2012;7:e34600.","journal-title":"PLoS ONE"},{"key":"4493_CR142","doi-asserted-by":"crossref","first-page":"101762","DOI":"10.1016\/j.redox.2020.101762","volume":"37","author":"LR Rodriguez","year":"2020","unstructured":"Rodriguez LR, Calap-Quintana P, Lapena-Luzon T, Pallardo FV, Schneuwly S, Navarro JA, Gonzalez-Cabo P. Oxidative stress modulates rearrangement of endoplasmic reticulum-mitochondria contacts and calcium dysregulation in a Friedreich\u2019s ataxia model. Redox Biol. 2020;37:101762.","journal-title":"Redox Biol"},{"key":"4493_CR143","doi-asserted-by":"crossref","first-page":"9840","DOI":"10.1038\/s41598-017-10320-2","volume":"7","author":"H Zhao","year":"2017","unstructured":"Zhao H, Li H, Hao S, Chen J, Wu J, Song C, Zhang M, Qiao T, Li K. Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia. Sci Rep. 2017;7:9840.","journal-title":"Sci Rep"},{"key":"4493_CR144","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134221","author":"M Igoillo-Esteve","year":"2020","unstructured":"Igoillo-Esteve M, Oliveira AF, Cosentino C, Fantuzzi F, Demarez C, Toivonen S, Hu A, Chintawar S, Lopes M, Pachera N, et al. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia. JCI Insight. 2020. https:\/\/doi.org\/10.1172\/jci.insight.134221.","journal-title":"JCI Insight"},{"key":"4493_CR145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuint.2017.08.002","volume":"117","author":"S Chiang","year":"2018","unstructured":"Chiang S, Kalinowski DS, Jansson PJ, Richardson DR, Huang ML. Mitochondrial dysfunction in the neuro-degenerative and cardio-degenerative disease. Friedreich\u2019s ataxia Neurochem Int. 2018;117:35\u201348.","journal-title":"Friedreich's ataxia Neurochem Int"},{"key":"4493_CR146","doi-asserted-by":"crossref","first-page":"e2237","DOI":"10.1038\/cddis.2016.111","volume":"7","author":"R Abeti","year":"2016","unstructured":"Abeti R, Parkinson MH, Hargreaves IP, Angelova PR, Sandi C, Pook MA, Giunti P, Abramov AY. Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich\u2019s ataxia. Cell Death Dis. 2016;7:e2237.","journal-title":"Cell Death Dis"},{"key":"4493_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030916","author":"P La Rosa","year":"2020","unstructured":"La Rosa P, Bertini ES, Piemonte F. The NRF2 signaling network defines clinical biomarkers and therapeutic opportunity in Friedreich\u2019s Ataxia. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21030916.","journal-title":"Int J Mol Sci"},{"key":"4493_CR148","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1096\/fj.15-275404","volume":"29","author":"AO Oyewole","year":"2015","unstructured":"Oyewole AO, Birch-Machin MA. Mitochondria-targeted antioxidants. FASEB J. 2015;29:4766\u201371.","journal-title":"FASEB J"},{"key":"4493_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/cells11071169","author":"P Bottoni","year":"2022","unstructured":"Bottoni P, Pontoglio A, Scara S, Pieroni L, Urbani A, Scatena R. Mitochondrial respiratory complexes as targets of drugs: the PPAR agonist example. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11071169.","journal-title":"Cells"},{"key":"4493_CR150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tips.2022.11.004","volume":"44","author":"E Zacharioudakis","year":"2023","unstructured":"Zacharioudakis E, Gavathiotis E. Mitochondrial dynamics proteins as emerging drug targets. Trends Pharmacol Sci. 2023;44:112\u201327.","journal-title":"Trends Pharmacol Sci"},{"key":"4493_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1217815","author":"NRR Luque-Campos","year":"2023","unstructured":"Luque-Campos NRR, Molina L, Canedo-Marroquin G, Vega-Letter AM, Luz-Crawford P, Bustamante-Barrientos FA. Exploring the therapeutic potential of the mitochondrial transfer-associated enzymatic machinery in brain degeneration. Front Physiol Sec Mitochon Res. 2023. https:\/\/doi.org\/10.3389\/fphys.2023.1217815.","journal-title":"Front Physiol Sec Mitochon Res"},{"key":"4493_CR152","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.7150\/thno.29400","volume":"9","author":"H Li","year":"2019","unstructured":"Li H, Wang C, He T, Zhao T, Chen YY, Shen YL, Zhang X, Wang LL. Mitochondrial transfer from bone marrow mesenchymal stem cells to motor neurons in spinal cord injury rats via gap junction. Theranostics. 2019;9:2017\u201335.","journal-title":"Theranostics"},{"key":"4493_CR153","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.2736","volume":"18","author":"MN Islam","year":"2012","unstructured":"Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, Rowlands DJ, Quadri SK, Bhattacharya S, Bhattacharya J. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18:759\u201365.","journal-title":"Nat Med"},{"key":"4493_CR154","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/0271678X20928147","volume":"41","author":"N Tseng","year":"2021","unstructured":"Tseng N, Lambie SC, Huynh CQ, Sanford B, Patel M, Herson PS, Ormond DR. Mitochondrial transfer from mesenchymal stem cells improves neuronal metabolism after oxidant injury in vitro: the role of Miro1. J Cereb Blood Flow Metab. 2021;41:761\u201370.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4493_CR155","doi-asserted-by":"crossref","first-page":"e48052","DOI":"10.15252\/embr.201948052","volume":"21","author":"AC Court","year":"2020","unstructured":"Court AC, Le-Gatt A, Luz-Crawford P, Parra E, Aliaga-Tobar V, Batiz LF, Contreras RA, Ortuzar MI, Kurte M, Elizondo-Vega R, et al. Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response. EMBO Rep. 2020;21:e48052.","journal-title":"EMBO Rep"},{"key":"4493_CR156","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature18928","volume":"535","author":"K Hayakawa","year":"2016","unstructured":"Hayakawa K, Esposito E, Wang X, Terasaki Y, Liu Y, Xing C, Ji X, Lo EH. Transfer of mitochondria from astrocytes to neurons after stroke. Nature. 2016;535:551\u20135.","journal-title":"Nature"},{"key":"4493_CR157","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s40478-018-0644-8","volume":"6","author":"N Boukelmoune","year":"2018","unstructured":"Boukelmoune N, Chiu GS, Kavelaars A, Heijnen CJ. Mitochondrial transfer from mesenchymal stem cells to neural stem cells protects against the neurotoxic effects of cisplatin. Acta Neuropathol Commun. 2018;6:139.","journal-title":"Acta Neuropathol Commun"},{"key":"4493_CR158","doi-asserted-by":"crossref","first-page":"E859","DOI":"10.1152\/ajpendo.00054.2021","volume":"320","author":"A Stier","year":"2021","unstructured":"Stier A. Human blood contains circulating cell-free mitochondria, but are they really functional? Am J Physiol Endocrinol Metab. 2021;320:E859\u201363.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4493_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070727","author":"LM Doyle","year":"2019","unstructured":"Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8070727.","journal-title":"Cells"},{"key":"4493_CR160","doi-asserted-by":"crossref","unstructured":"Peruzzotti-Jametti L, Bernstock JD, Manferrari G, Rogall R, Fernandez-Vizarra E, Williamson JC, Braga A, van den Bosch A, Leonardi T, Kittel \u00c1, et al. Neural stem cells traffic functional mitochondria via extracellular vesicles to correct mitochondrial dysfunction in target cells. bioRxiv. 2020.","DOI":"10.1101\/2020.01.29.923441"},{"key":"4493_CR161","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.febslet.2007.03.071","volume":"581","author":"HH Gerdes","year":"2007","unstructured":"Gerdes HH, Bukoreshtliev NV, Barroso JF. Tunneling nanotubes: a new route for the exchange of components between animal cells. FEBS Lett. 2007;581:2194\u2013201.","journal-title":"FEBS Lett"},{"key":"4493_CR162","doi-asserted-by":"crossref","first-page":"7610414","DOI":"10.1155\/2017\/7610414","volume":"2017","author":"A Caicedo","year":"2017","unstructured":"Caicedo A, Aponte PM, Cabrera F, Hidalgo C, Khoury M. Artificial mitochondria transfer: current challenges, advances, and future applications. Stem Cells Int. 2017;2017:7610414.","journal-title":"Stem Cells Int"},{"key":"4493_CR163","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13287-019-1307-9","volume":"10","author":"P Luz-Crawford","year":"2019","unstructured":"Luz-Crawford P, Hernandez J, Djouad F, Luque-Campos N, Caicedo A, Carrere-Kremer S, Brondello JM, Vignais ML, Pene J, Jorgensen C. Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer. Stem Cell Res Ther. 2019;10:232.","journal-title":"Stem Cell Res Ther"},{"key":"4493_CR164","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fncel.2018.00320","volume":"12","author":"A Dong","year":"2018","unstructured":"Dong A, Liu S, Li Y. Gap junctions in the nervous system: probing functional connections using new imaging approaches. Front Cell Neurosci. 2018;12:320.","journal-title":"Front Cell Neurosci"},{"key":"4493_CR165","doi-asserted-by":"crossref","first-page":"24128","DOI":"10.1074\/jbc.M802996200","volume":"283","author":"A Nakajima","year":"2008","unstructured":"Nakajima A, Kurihara H, Yagita H, Okumura K, Nakano H. Mitochondrial extrusion through the cytoplasmic vacuoles during cell death. J Biol Chem. 2008;283:24128\u201335.","journal-title":"J Biol Chem"},{"key":"4493_CR166","doi-asserted-by":"crossref","first-page":"165963","DOI":"10.1016\/j.bbadis.2020.165963","volume":"1866","author":"SD Padilla-Sanchez","year":"2020","unstructured":"Padilla-Sanchez SD, Navarrete D, Caicedo A, Teran E. Circulating cell-free mitochondrial DNA levels correlate with body mass index and age. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165963.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4493_CR167","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1038\/srep09073","volume":"5","author":"A Caicedo","year":"2015","unstructured":"Caicedo A, Fritz V, Brondello JM, Ayala M, Dennemont I, Abdellaoui N, de Fraipont F, Moisan A, Prouteau CA, Boukhaddaoui H, et al. MitoCeption as a new tool to assess the effects of mesenchymal stem\/stromal cell mitochondria on cancer cell metabolism and function. Sci Rep. 2015;5:9073.","journal-title":"Sci Rep"},{"key":"4493_CR168","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mito.2017.02.005","volume":"34","author":"X Shi","year":"2017","unstructured":"Shi X, Zhao M, Fu C, Fu A. Intravenous administration of mitochondria for treating experimental Parkinson\u2019s disease. Mitochondrion. 2017;34:91\u2013100.","journal-title":"Mitochondrion"},{"key":"4493_CR169","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.yjmcc.2014.09.014","volume":"76","author":"ER Pfeiffer","year":"2014","unstructured":"Pfeiffer ER, Wright AT, Edwards AG, Stowe JC, McNall K, Tan J, Niesman I, Patel HH, Roth DM, Omens JH, McCulloch AD. Caveolae in ventricular myocytes are required for stretch-dependent conduction slowing. J Mol Cell Cardiol. 2014;76:265\u201374.","journal-title":"J Mol Cell Cardiol"},{"key":"4493_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144995","author":"D Kami","year":"2020","unstructured":"Kami D, Gojo S. From cell entry to engraftment of exogenous mitochondria. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21144995.","journal-title":"Int J Mol Sci"},{"key":"4493_CR171","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/jcmm.12316","volume":"18","author":"T Kitani","year":"2014","unstructured":"Kitani T, Kami D, Matoba S, Gojo S. Internalization of isolated functional mitochondria: involvement of macropinocytosis. J Cell Mol Med. 2014;18:1694\u2013703.","journal-title":"J Cell Mol Med"},{"key":"4493_CR172","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1242\/bio.201511478","volume":"4","author":"CA Pacak","year":"2015","unstructured":"Pacak CA, Preble JM, Kondo H, Seibel P, Levitsky S, Del Nido PJ, Cowan DB, McCully JD. Actin-dependent mitochondrial internalization in cardiomyocytes: evidence for rescue of mitochondrial function. Biol Open. 2015;4:622\u20136.","journal-title":"Biol Open"},{"key":"4493_CR173","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1038\/s41598-017-17813-0","volume":"7","author":"DB Cowan","year":"2017","unstructured":"Cowan DB, Yao R, Thedsanamoorthy JK, Zurakowski D, Del Nido PJ, McCully JD. Transit and integration of extracellular mitochondria in human heart cells. Sci Rep. 2017;7:17450.","journal-title":"Sci Rep"},{"key":"4493_CR174","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40478-020-00897-7","volume":"8","author":"K English","year":"2020","unstructured":"English K, Shepherd A, Uzor NE, Trinh R, Kavelaars A, Heijnen CJ. Astrocytes rescue neuronal health after cisplatin treatment through mitochondrial transfer. Acta Neuropathol Commun. 2020;8:36.","journal-title":"Acta Neuropathol Commun"},{"issue":"613\u2013626","key":"4493_CR175","first-page":"e619","volume":"110","author":"M van der Vlist","year":"2022","unstructured":"van der Vlist M, Raoof R, Willemen H, Prado J, Versteeg S, Martin Gil C, Vos M, Lokhorst RE, Pasterkamp RJ, Kojima T, et al. Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain. Neuron. 2022;110(613\u2013626):e619.","journal-title":"Neuron"},{"key":"4493_CR176","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/stem.2856","volume":"36","author":"K Hayakawa","year":"2018","unstructured":"Hayakawa K, Chan SJ, Mandeville ET, Park JH, Bruzzese M, Montaner J, Arai K, Rosell A, Lo EH. Protective effects of endothelial progenitor cell-derived extracellular mitochondria in brain endothelium. Stem Cells. 2018;36:1404\u201310.","journal-title":"Stem Cells"},{"key":"4493_CR177","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1038\/s41598-021-90115-8","volume":"11","author":"JS Do","year":"2021","unstructured":"Do JS, Zwick D, Kenyon JD, Zhong F, Askew D, Huang AY, Van\u2019t Hof W, Finney M, Laughlin MJ. Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability. Sci Rep. 2021;11:10676.","journal-title":"Sci Rep"},{"key":"4493_CR178","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fncel.2019.00316","volume":"13","author":"L Gao","year":"2019","unstructured":"Gao L, Zhang Z, Lu J, Pei G. Mitochondria are dynamically transferring between human neural cells and alexander disease-associated GFAP mutations impair the astrocytic transfer. Front Cell Neurosci. 2019;13:316.","journal-title":"Front Cell Neurosci"},{"key":"4493_CR179","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00018-003-3143-3","volume":"61","author":"C Mignot","year":"2004","unstructured":"Mignot C, Boespflug-Tanguy O, Gelot A, Dautigny A, Pham-Dinh D, Rodriguez D. Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cell Mol Life Sci. 2004;61:369\u201385.","journal-title":"Cell Mol Life Sci"},{"key":"4493_CR180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.stem.2015.09.003","volume":"17","author":"AM Bond","year":"2015","unstructured":"Bond AM, Ming GL, Song H. Adult mammalian neural stem cells and neurogenesis: five decades later. Cell Stem Cell. 2015;17:385\u201395.","journal-title":"Cell Stem Cell"},{"key":"4493_CR181","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1073\/pnas.1404651111","volume":"111","author":"CH Davis","year":"2014","unstructured":"Davis CH, Kim KY, Bushong EA, Mills EA, Boassa D, Shih T, Kinebuchi M, Phan S, Zhou Y, Bihlmeyer NA, et al. Transcellular degradation of axonal mitochondria. Proc Natl Acad Sci U S A. 2014;111:9633\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4493_CR182","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","volume":"42","author":"AK Jha","year":"2015","unstructured":"Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, Chmielewski K, Stewart KM, Ashall J, Everts B, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015;42:419\u201330.","journal-title":"Immunity"},{"key":"4493_CR183","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4252\/wjsc.v6.i2.134","volume":"6","author":"F Appaix","year":"2014","unstructured":"Appaix F, Nissou MF, van der Sanden B, Dreyfus M, Berger F, Issartel JP, Wion D. Brain mesenchymal stem cells: the other stem cells of the brain? World J Stem Cells. 2014;6:134\u201343.","journal-title":"World J Stem Cells"},{"key":"4493_CR184","doi-asserted-by":"crossref","first-page":"H94","DOI":"10.1152\/ajpheart.00567.2008","volume":"296","author":"JD McCully","year":"2009","unstructured":"McCully JD, Cowan DB, Pacak CA, Toumpoulis IK, Dayalan H, Levitsky S. Injection of isolated mitochondria during early reperfusion for cardioprotection. Am J Physiol Heart Circ Physiol. 2009;296:H94\u2013105.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4493_CR185","doi-asserted-by":"crossref","first-page":"e0160889","DOI":"10.1371\/journal.pone.0160889","volume":"11","author":"DB Cowan","year":"2016","unstructured":"Cowan DB, Yao R, Akurathi V, Snay ER, Thedsanamoorthy JK, Zurakowski D, Ericsson M, Friehs I, Wu Y, Levitsky S, et al. Intracoronary delivery of mitochondria to the ischemic heart for cardioprotection. PLoS ONE. 2016;11:e0160889.","journal-title":"PLoS ONE"},{"key":"4493_CR186","doi-asserted-by":"crossref","first-page":"H966","DOI":"10.1152\/ajpheart.00883.2012","volume":"304","author":"A Masuzawa","year":"2013","unstructured":"Masuzawa A, Black KM, Pacak CA, Ericsson M, Barnett RJ, Drumm C, Seth P, Bloch DB, Levitsky S, Cowan DB, McCully JD. Transplantation of autologously derived mitochondria protects the heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2013;304:H966-982.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4493_CR187","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jtcvs.2017.02.018","volume":"154","author":"SM Emani","year":"2017","unstructured":"Emani SM, Piekarski BL, Harrild D, Del Nido PJ, McCully JD. Autologous mitochondrial transplantation for dysfunction after ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2017;154:286\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4493_CR188","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41536-020-00107-x","volume":"5","author":"P Norat","year":"2020","unstructured":"Norat P, Soldozy S, Sokolowski JD, Gorick CM, Kumar JS, Chae Y, Yagmurlu K, Prada F, Walker M, Levitt MR, et al. Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation. NPJ Regen Med. 2020;5:22.","journal-title":"NPJ Regen Med"},{"key":"4493_CR189","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jtcvs.2016.10.077","volume":"153","author":"AK Kaza","year":"2017","unstructured":"Kaza AK, Wamala I, Friehs I, Kuebler JD, Rathod RH, Berra I, Ericsson M, Yao R, Thedsanamoorthy JK, Zurakowski D, et al. Myocardial rescue with autologous mitochondrial transplantation in a porcine model of ischemia\/reperfusion. J Thorac Cardiovasc Surg. 2017;153:934\u201343.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4493_CR190","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbr.2018.09.005","volume":"356","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Ma Z, Yan C, Pu K, Wu M, Bai J, Li Y, Wang Q. Muscle-derived autologous mitochondrial transplantation: a novel strategy for treating cerebral ischemic injury. Behav Brain Res. 2019;356:322\u201331.","journal-title":"Behav Brain Res"},{"key":"4493_CR191","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMcibr1615669","volume":"376","author":"M Herbert","year":"2017","unstructured":"Herbert M, Turnbull D. Mitochondrial donation\u2014clearing the final regulatory hurdle in the United Kingdom. N Engl J Med. 2017;376:171\u20133.","journal-title":"N Engl J Med"},{"key":"4493_CR192","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/imj.15925","volume":"52","author":"PA Komesaroff","year":"2022","unstructured":"Komesaroff PA, Kerridge I, Norman RJ. Mitochondrial donation is now possible: science must now ensure that it is safe. Intern Med J. 2022;52:1663\u20135.","journal-title":"Intern Med J"},{"key":"4493_CR193","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/14647273.2021.1925168","volume":"25","author":"C Siristatidis","year":"2022","unstructured":"Siristatidis C, Mantzavinos T, Vlahos N. Maternal spindle transfer for mitochondrial disease: lessons to be learnt before extending the method to other conditions? Hum Fertil (Camb). 2022;25:838\u201347.","journal-title":"Hum Fertil (Camb)"},{"key":"4493_CR194","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature19105","volume":"538","author":"LA Hyslop","year":"2016","unstructured":"Hyslop LA, Blakeley P, Craven L, Richardson J, Fogarty NM, Fragouli E, Lamb M, Wamaitha SE, Prathalingam N, Zhang Q, et al. Corrigendum: towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease. Nature. 2016;538:542.","journal-title":"Nature"},{"key":"4493_CR195","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2014.04.042","volume":"157","author":"T Wang","year":"2014","unstructured":"Wang T, Sha H, Ji D, Zhang HL, Chen D, Cao Y, Zhu J. Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases. Cell. 2014;157:1591\u2013604.","journal-title":"Cell"},{"key":"4493_CR196","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fncel.2016.00219","volume":"10","author":"A Paine","year":"2016","unstructured":"Paine A, Jaiswal MK. Promise and pitfalls of mitochondrial replacement for prevention and cure of heritable neurodegenerative diseases caused by deleterious mutations in mitochondrial DNA. Front Cell Neurosci. 2016;10:219.","journal-title":"Front Cell Neurosci"},{"key":"4493_CR197","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/humrep\/deaa308","volume":"36","author":"H Ma","year":"2021","unstructured":"Ma H, Van Dyken C, Darby H, Mikhalchenko A, Marti-Gutierrez N, Koski A, Liang D, Li Y, Tippner-Hedges R, Kang E, et al. Germline transmission of donor, maternal and paternal mtDNA in primates. Hum Reprod. 2021;36:493\u2013505.","journal-title":"Hum Reprod"},{"key":"4493_CR198","doi-asserted-by":"crossref","first-page":"785761","DOI":"10.3389\/fnagi.2022.785761","volume":"14","author":"L Gao","year":"2022","unstructured":"Gao L, Liu F, Hou PP, Manaenko A, Xiao ZP, Wang F, Xu TL, Hu Q. Neurons release injured mitochondria as \u201cHelp-Me\u201d Signaling after ischemic stroke. Front Aging Neurosci. 2022;14:785761.","journal-title":"Front Aging Neurosci"},{"key":"4493_CR199","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3727\/096368915X689785","volume":"25","author":"PJ Huang","year":"2016","unstructured":"Huang PJ, Kuo CC, Lee HC, Shen CI, Cheng FC, Wu SF, Chang JC, Pan HC, Lin SZ, Liu CS, Su HL. Transferring Xenogenic mitochondria provides neural protection against ischemic stress in ischemic rat brains. Cell Transplant. 2016;25:913\u201327.","journal-title":"Cell Transplant"},{"key":"4493_CR200","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1161\/STROKEAHA.117.017758","volume":"48","author":"SH Chou","year":"2017","unstructured":"Chou SH, Lan J, Esposito E, Ning M, Balaj L, Ji X, Lo EH, Hayakawa K. Extracellular mitochondria in cerebrospinal fluid and neurological recovery after subarachnoid hemorrhage. Stroke. 2017;48:2231\u20137.","journal-title":"Stroke"},{"key":"4493_CR201","doi-asserted-by":"crossref","first-page":"C755","DOI":"10.1152\/ajpcell.1990.258.5.C755","volume":"258","author":"TE Gunter","year":"1990","unstructured":"Gunter TE, Pfeiffer DR. Mechanisms by which mitochondria transport calcium. Am J Physiol. 1990;258:C755-786.","journal-title":"Am J Physiol"},{"key":"4493_CR202","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bpj.2018.08.044","volume":"115","author":"ML Valentine","year":"2018","unstructured":"Valentine ML, Cardenas AE, Elber R, Baiz CR. Physiological calcium concentrations slow dynamics at the lipid-water interface. Biophys J. 2018;115:1541\u201351.","journal-title":"Biophys J"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04493-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04493-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04493-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T15:33:22Z","timestamp":1700321602000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04493-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,9]]},"references-count":202,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4493"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04493-w","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,9]]},"assertion":[{"value":"6 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the last version of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"613"}}